![]() |
市场调查报告书
商品编码
1452614
南美洲和中美洲深脑模拟市场预测至 2030 年 - 区域分析 - 按产品、应用和最终用户South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User |
南美洲和中美洲深部脑部模拟市场预计将从2022年的2,753万美元成长到2030年的5,095万美元。预计2022年至2030年CAGR为8.0%。
对微创手术的需求不断增长推动南美洲和中美洲深部脑部模拟市场
深部脑部刺激是一种微创标靶手术,用于治疗肌张力失调、帕金森氏症和特发性震颤等运动障碍。微创手术 (MIS) 与传统手术技术相比具有多种优势。 MIS 可最大程度地减少对身体的创伤,减少术后疼痛,提高恢復速度并改善结果。机器人手术代表了微创手术的最新发展,为外科医生提供了使用与传统腹腔镜检查相同的小切口的精密设备。与开放性手术相比,MIS 可以减少失血量、减少止痛剂的使用、缩短术后住院时间。此外,微创手术比传统手术方法的准确率更高。此外,这些手术需要足够大的微小切口来插入细管和相机。 MIS 的这些好处正在增加住院患者的数量,并鼓励面临高手术发病率和死亡率的老年患者寻求手术。因此,微创手术因其优势而不断增长的需求促进了南美洲和中美洲深部脑部刺激(DBS)市场的成长。
南美洲和中美洲深脑模拟市场概述
在巴西,人口老化正在迅速成长。根据泛美卫生组织(PAHO)的资料,巴西60岁以上人口超过3,000万,占全国人口的13%。到 2030 年,这一年龄层的人口预计将达到约 5,000 万,占巴西人口的 24%。根据巴西统计局的数据,到2050年,该国65岁及以上的人口预计将占巴西总人口的36%。此外,神经系统疾病的盛行率取决于巴西的老年人口;因此,帕金森氏症和阿兹海默症等神经系统疾病发病率的增加可能会推动对深部脑部刺激(DBS)治疗的需求。此外,根据2023 年发表的研究《2000-2019 年巴西阿兹海默症死亡率趋势》,在巴西,由于人口日益老化,加上死亡率不断上升,阿兹海默症已成为一个主要的健康问题以及该疾病在该国日益普及。 2009年至2019年间,该国因阿兹海默症死亡的人数增加了49%,使其成为第七大死因。巴西同期有超过 211,600 人死于该疾病。此外,73%的死亡人数为80岁以上,27%为60-79岁年龄层。因此,预计上述因素将在未来几年增加该国对 DBS 设备用于治疗疾病的需求。
南美洲和中美洲深脑模拟市场收入及 2030 年预测(百万美元)
南美洲和中美洲深脑模拟市场细分
南美洲和中美洲深脑模拟市场分为产品、应用、最终用户和国家。
根据产品,南美洲和中美洲深部脑模拟市场分为单通道深部脑部刺激器、双通道深部脑部刺激器以及软体和配件。 2022年,双通道深部脑部刺激器细分市场在中南美洲深部脑部模拟市场中占据最大份额。
根据应用,南美洲和中美洲深部脑模拟市场分为帕金森氏症、震颤、肌张力失调、癫痫、阿兹海默症等。 2022年,帕金森氏症领域在南美洲和中美洲深部脑部模拟市场中占据最大份额。
根据最终用户,南美洲和中美洲深部脑部模拟市场分为医院、神经科诊所、门诊手术中心等。 2022年,医院领域在南美洲和中美洲深部脑部模拟市场中占据最大份额。
根据国家/地区,南美洲和中美洲深脑模拟市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022年,巴西在南美洲和中美洲深部脑部模拟市场中占据最大份额。
雅培 (Abbott)、美敦力 (Medtronic)、波士顿科学 (Boston Sci) 和 Leva Nova 是南美洲和中美洲深脑模拟市场的一些领先公司。
The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in 2022 to US$ 50.95 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.
Increasing Demand for Minimally Invasive Surgery Drive South & Central America Deep Brain Simulation Market
Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the South & Central America deep brain stimulation (DBS) market growth.
South & Central America Deep Brain Simulation Market Overview
In Brazil, the aging population is rapidly growing. According to the data from Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and older, representing 13% of the country's population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazil Statistical Institute, the country's population aged 65 and above is expected to hold 36% share of the total population of Brazil by 2050. Further, the prevalence of neurological disorders is dependent on the geriatric population in Brazil; thus, the increasing incidences of neurological diseases, such as Parkinson's disease and Alzheimer's disease, are likely to propel the demand for deep brain stimulation (DBS) for treatment. Moreover, as per the study, "Trends in mortality from Alzheimer's disease in Brazil, 2000-2019," published in 2023, in Brazil, Alzheimer's disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country. During 2009-2019, there was a 49% increase in deaths due to Alzheimer's disease in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to the disease in the same period in Brazil. Furthermore, 73% of the deaths were of people aged 80 and above, and 27% were in the 60-79 age group. Thus, the above-mentioned factors are expected to increase the demand for DBS devices for the treatment of diseases in the country in the coming years.
South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Deep Brain Simulation Market Segmentation
The South & Central America deep brain simulation market is segmented into product, application, end user, and country.
Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the South & Central America deep brain simulation market.
Based on application, the South & Central America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the South & Central America deep brain simulation market.
Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the South & Central America deep brain simulation market.
Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America deep brain simulation market.
Abbott, Medtronic, Boston Sci, and Leva Nova are some of the leading companies operating in the South & Central America deep brain simulation market.